Novartis AG

Symbol: NVS

NYSE

100.21

USD

Market price today

  • 13.4358

    P/E Ratio

  • -3.1060

    PEG Ratio

  • 196.06B

    MRK Cap

  • 0.04%

    DIV Yield

Novartis AG (NVS) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.73%

Operating Profit Margin

0.22%

Net Profit Margin

0.31%

Return on Assets

0.16%

Return on Equity

0.35%

Return on Capital Employed

0.17%

Company general description and statistics

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO:Dr. Vasant Narasimhan M.D.
Full-time employees:76057
City:Basel
Address:Lichtstrasse 35
IPO:1996-11-07
CIK:0001114448

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

General Outlook

When we look at how much money they make before expenses, they keep 0.726% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.219%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.307%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.162% return, is a testament to Novartis AG's adeptness in optimizing resource deployment. Novartis AG's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.346%. Furthermore, the proficiency of Novartis AG in capital utilization is underscored by a remarkable 0.167% return on capital employed.

Stock Prices

Novartis AG's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $97.87, while its low point bottomed out at $96.72. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Novartis AG's stock market.

Liquidity Ratios

Analyzing NVS liquidity ratios reveals its financial health of the firm. The current ratio of 90.30% gauges short-term asset coverage for liabilities. The quick ratio (61.27%) assesses immediate liquidity, while the cash ratio (32.33%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio90.30%
Quick Ratio61.27%
Cash Ratio32.33%

Profitability Ratios

NVS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 19.86% underscores its earnings before tax deductions. The effective tax rate stands at 6.81%, revealing its tax efficiency. The net income per EBT, 154.68%, and the EBT per EBIT, 90.48%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 21.95%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin19.86%
Effective Tax Rate6.81%
Net Income per EBT154.68%
EBT per EBIT90.48%
EBIT per Revenue21.95%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.90, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding61
Days of Inventory Outstanding154
Operating Cycle214.70
Days of Payables Outstanding109
Cash Conversion Cycle106
Receivables Turnover6.02
Payables Turnover3.35
Inventory Turnover2.37
Fixed Asset Turnover4.71
Asset Turnover0.53

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 6.73, and free cash flow per share, 4.96, depict cash generation on a per-share basis. The cash per share value, 4.74, showcases liquidity position. A payout ratio of 0.34 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.28, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share6.73
Free Cash Flow per Share4.96
Cash per Share4.74
Payout Ratio0.34
Operating Cash Flow Sales Ratio0.28
Free Cash Flow to Operating Cash Flow Ratio0.74
Cash Flow Coverage Ratio0.53
Short Term Coverage Ratio1.61
Capital Expenditure Coverage Ratio3.80
Dividend Paid and Capex Coverage Ratio1.56
Dividend Payout Ratio0.03

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 27.30%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.65, we discern the balance between debt and equity financing. The long-term debt to capitalization, 30.23%, and total debt to capitalization, 39.36%, ratios shed light on its capital structure. An interest coverage of 12.32 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio27.30%
Debt Equity Ratio0.65
Long Term Debt to Capitalization30.23%
Total Debt to Capitalization39.36%
Interest Coverage12.32
Cash Flow to Debt Ratio0.53
Company Equity Multiplier2.38

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 22.47, provides a glimpse into top-line earnings distributed across each share. Net income per share, 7.15, reflects the portion of profit attributed to each share. The book value per share, 22.47, represents the net asset value distributed per share, while the tangible book value per share, -1.67, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share22.47
Net Income Per Share7.15
Book Value Per Share22.47
Tangible Book Value Per Share-1.67
Shareholders Equity Per Share22.47
Interest Debt Per Share13.10
Capex Per Share-1.33

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -9.97%, indicates top-line expansion, while the gross profit growth, -5.93%, reveals profitability trends. EBIT growth, 6.22%, and operating income growth, 6.22%, offer insights into operational profitability progression. The net income growth, 113.52%, showcases bottom-line expansion, and the EPS growth, 124.14%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-9.97%
Gross Profit Growth-5.93%
EBIT Growth6.22%
Operating Income Growth6.22%
Net Income Growth113.52%
EPS Growth124.14%
EPS Diluted Growth123.97%
Weighted Average Shares Growth-4.79%
Weighted Average Shares Diluted Growth-4.78%
Dividends per Share Growth1.51%
Operating Cash Flow Growth1.56%
Free Cash Flow Growth1.21%
10-Year Revenue Growth per Share-6.78%
5-Year Revenue Growth per Share-2.00%
3-Year Revenue Growth per Share2.53%
10-Year Operating CF Growth per Share28.99%
5-Year Operating CF Growth per Share13.12%
3-Year Operating CF Growth per Share16.13%
10-Year Net Income Growth per Share90.24%
5-Year Net Income Growth per Share31.49%
3-Year Net Income Growth per Share101.71%
10-Year Shareholders Equity Growth per Share-26.22%
5-Year Shareholders Equity Growth per Share-33.71%
3-Year Shareholders Equity Growth per Share-9.60%
10-Year Dividend per Share Growth per Share39.79%
5-Year Dividend per Share Growth per Share16.30%
3-Year Dividend per Share Growth per Share13.85%
Receivables Growth12.50%
Inventory Growth-17.59%
Asset Growth-14.91%
Book Value per Share Growth-17.41%
Debt Growth-5.78%
R&D Expense Growth13.76%
SGA Expenses Growth-12.18%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 222,711,208,140, captures the company's total value, considering both debt and equity. Income quality, 1.69, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 50.25%, indicates the value of non-physical assets, and capex to operating cash flow, -19.04%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value222,711,208,140
Income Quality1.69
Research and Development to Revenue24.37%
Intangibles to Total Assets50.25%
Capex to Operating Cash Flow-19.04%
Capex to Revenue-5.90%
Capex to Depreciation-33.26%
Stock-Based Compensation to Revenue1.85%
Graham Number60.13
Return on Tangible Assets29.86%
Graham Net Net-14.08
Working Capital4,091,000,000
Tangible Asset Value-3,470,000,000
Net Current Asset Value-22,714,000,000
Invested Capital1
Average Receivables8,855,000,000
Average Payables5,036,000,000
Average Inventory6,544,000,000
Days Sales Outstanding73
Days Payables Outstanding144
Days of Inventory On Hand173
ROIC12.57%
ROE0.32%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 5.16, and the price to book ratio, 5.16, reflect the market's valuation relative to the company's book value. The price to sales ratio, 3.95, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 19.32, and price to operating cash flows, 14.88, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio5.16
Price to Book Ratio5.16
Price to Sales Ratio3.95
Price Cash Flow Ratio14.88
Price Earnings to Growth Ratio-3.11
Enterprise Value Multiple9.47
Price Fair Value5.16
Price to Operating Cash Flow Ratio14.88
Price to Free Cash Flows Ratio19.32
Price to Tangible Book Ratio4.49
Enterprise Value to Sales4.77
Enterprise Value Over EBITDA12.06
EV to Operating Cash Flow15.40
Earnings Yield7.08%
Free Cash Flow Yield5.58%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Novartis AG (NVS) on the NYSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 13.436 in 2024.

What is the ticker symbol of Novartis AG stock?

The ticker symbol of Novartis AG stock is NVS.

What is company IPO date?

IPO date of Novartis AG is 1996-11-07.

What is company current share price?

Current share price is 100.210 USD.

What is stock market cap today?

The market cap of stock today is 196059485509.000.

What is PEG ratio in 2024?

The current -3.106 is -3.106 in 2024.

What is the number of employees in 2024?

In 2024 the company has 76057.